A Breakthrough: Macrophage-Directed Cancer Immunotherapy.
about
New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor ImmunotherapyCytomegalovirus, Macrophages and Breast Cancer.Secondary bile acid-induced dysbiosis promotes intestinal carcinogenesis.Fucoidan inhibits CCL22 production through NF-κB pathway in M2 macrophages: a potential therapeutic strategy for cancer.Heparanase is required for activation and function of macrophages.Anti-SIRPα antibodies as a potential new tool for cancer immunotherapy.IL-1α and IL-1β-producing macrophages populate lung tumor lesions in miceDistinct patterns and prognostic values of tumor-infiltrating macrophages in hepatocellular carcinoma and gastric cancer.Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors.Targeted therapy for soft tissue sarcomas in adolescents and young adults.Paclitaxel nanoparticle awakens immune system to fight against cancer.Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific Antibodies.To b(ortezomib) or not to be: the stroma's the thing.AllergoOncology - the impact of allergy in oncology: EAACI position paper.The importance of correctly timing cancer immunotherapy.Concise Review: An (Im)Penetrable Shield: How the Tumor Microenvironment Protects Cancer Stem Cells.The Dr. Jekyll and Mr. Hyde complexity of the macrophage response in disease.Zoledronic acid renders human M1 and M2 macrophages susceptible to Vδ2(+) γδ T cell cytotoxicity in a perforin-dependent manner.The Anti-Tumor Effects of M1 Macrophage-Loaded Poly (ethylene glycol) and Gelatin-Based Hydrogels on Hepatocellular Carcinoma.Iron Induces Anti-tumor Activity in Tumor-Associated Macrophages.Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone.Mining the Complex Family of Protein Tyrosine Phosphatases for Checkpoint Regulators in Immunity.M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma.Clinical evaluation of macrophages in cancer: role in treatment, modulation and challenges.M1 Means Kill; M2 Means Heal.Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer.Bindarit Attenuates Pain and Cancer-Related Inflammation by Influencing Myeloid Cells in a Model of Bone Cancer.An obligatory anaerobic Salmonella typhimurium strain redirects M2 macrophages to the M1 phenotype.Phenotypical change of tumor-associated macrophages in metastatic lesions of clear cell renal cell carcinoma.Expression of adipocyte/macrophage fatty acid binding protein in tumor associated macrophages promotes breast cancer progression.Engineering mechanical microenvironment of macrophage and its biomedical applications.Chemotherapeutic tumor microparticles combining low-dose irradiation reprogram tumor-promoting macrophages through a tumor-repopulating cell-curtailing pathway.The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration.NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients.Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer.Dual-targeting biomimetic delivery for anti-glioma activity via remodeling the tumor microenvironment and directing macrophage-mediated immunotherapy.Biomimetic albumin-modified gold nanorods for photothermo-chemotherapy and macrophage polarization modulation.Immunomodulatory activities of pixatimod: emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitors.Immuno-Oncology: Emerging Targets and Combination TherapiesCXCL1 derived from tumor-associated macrophages promotes breast cancer metastasis via activating NF-κB/SOX4 signaling
P2860
Q28072045-BA1988BE-B84C-4A7F-BCD9-1959C6BDC4D4Q33645055-C2477FC4-FECB-48F1-95BF-380D57F9621AQ36277271-89938851-4389-42AD-8320-833F44AF316FQ37360097-F7E297CE-728C-4A32-8924-5D00145ADB67Q37473740-0FEA0875-7BC3-416E-A2C8-ED7173AE803CQ37558139-543540A4-B56C-40BE-8904-1254BD2FFDC5Q37629006-2B837B33-EEF7-4093-8923-1B05F0A1E133Q37645527-8E4195F4-5AA1-4284-8791-8E8EEDEC9C53Q37660216-635ED0F3-0FD4-4AFC-AF93-80EB2AD447CBQ37742014-3FC904DE-7FFE-43CE-B653-E95A206D32D1Q38688207-18470947-BAB7-49EB-B7AA-2657A35487D5Q38718295-CD661D23-70C3-414E-9691-5317B403CD34Q38762531-69426B84-8E58-4546-9570-DCBEF820BFF2Q38776716-1B2BD835-8BFC-4CC9-9456-5B3D3E25C80AQ38995979-E660DE7D-C7B4-401D-BBA6-375D02B1E616Q39138664-395198DA-3EC0-4391-B484-A0A2413479D3Q39188002-B134D2E1-E5D4-491C-BDF3-AD4D62D260E7Q40213985-62E28399-C02C-44A3-AE98-0053C9B45212Q45419347-AA44919E-4C35-4F4F-A976-2863E1A7BF78Q47161414-220B93D8-5C15-4418-8492-F0B5D01508A6Q47286257-3A7A2E32-19E2-4F8C-8EB1-92ABD3F7E763Q47774258-A67E63B7-4BFE-4FBB-B846-DC583EA449BBQ48269732-4E0125B8-7DF3-41A9-8D1E-6B49B406468FQ48290538-FDD691C9-BA17-4B9B-9281-3031947BE8FBQ48327546-C87DF8BD-A322-4E62-84F9-F86828B04AA9Q49723815-F708C739-25A3-4DED-9C8B-7C68225C2D2AQ49874716-41B4CE91-2EF9-4478-9210-069651C328F0Q49874816-0113F487-D1F8-4454-9350-9B9A672364B4Q50017705-C4FB8A75-F044-48B3-B4A9-28B6DD998EB2Q50044116-1EA9778D-F542-4BDD-B103-C1FED0606430Q50046074-A881D471-C143-4A42-9369-BE70BFB88E62Q50619471-19583E6D-B79F-4700-8434-97905EF7E2CBQ51360609-4252879A-AE01-4ABA-B783-65230AD9C3A5Q52664398-D7127492-6901-41D0-A6FD-2A9D1E3E83EDQ55021572-B1A1A3AC-CD57-45B0-BE04-48C4AA47B333Q55300546-C239825C-CAC2-4F68-A8ED-B24A9C82FBE3Q55363678-A7AD4BB8-AD4C-486F-835F-DFA35ABAABB5Q55414494-A44DA8B8-4EDB-49C4-A6B2-14338994F7B2Q56889817-5F73CD68-3812-4B82-847C-5AC84847FA83Q58695499-F325025F-1A4A-477F-B4A0-2A841845ED4F
P2860
A Breakthrough: Macrophage-Directed Cancer Immunotherapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
A Breakthrough: Macrophage-Directed Cancer Immunotherapy.
@en
type
label
A Breakthrough: Macrophage-Directed Cancer Immunotherapy.
@en
prefLabel
A Breakthrough: Macrophage-Directed Cancer Immunotherapy.
@en
P2860
P1433
P1476
A Breakthrough: Macrophage-Directed Cancer Immunotherapy
@en
P2093
Charles D Mills
Robert A Harris
P2860
P304
P356
10.1158/0008-5472.CAN-15-1737
P407
P577
2016-01-15T00:00:00Z